• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MED25 是 HNF4α 驱动的转录的中介成分,导致胰岛β细胞中的胰岛素分泌。

MED25 is a mediator component of HNF4α-driven transcription leading to insulin secretion in pancreatic beta-cells.

机构信息

Section of Structural Biology, Hormel Institute, University of Minnesota, Austin, Minnesota, United States of America.

出版信息

PLoS One. 2012;7(8):e44007. doi: 10.1371/journal.pone.0044007. Epub 2012 Aug 30.

DOI:10.1371/journal.pone.0044007
PMID:22952853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3431373/
Abstract

Unique nuclear receptor Hepatocyte Nuclear Factor 4α (HNF4α) is an essential transcriptional regulator for early development and proper function of pancreatic ß-cells, and its mutations are monogenic causes of a dominant inherited form of diabetes referred to as Maturity Onset Diabetes of the Young 1 (MODY1). As a gene-specific transcription factor, HNF4α exerts its function through various molecular interactions, but its protein recruiting network has not been fully characterized. Here we report the identification of MED25 as one of the HNF4α binding partners in pancreatic ß-cells leading to insulin secretion which is impaired in MODY patients. MED25 is one of the subunits of the Mediator complex that is required for induction of RNA polymerase II transcription by various transcription factors including nuclear receptors. This HNF4α-MED25 interaction was initially identified by a yeast-two-hybrid method, confirmed by in vivo and in vitro analyses, and proven to be mediated through the MED25-LXXLL motif in a ligand-independent manner. Reporter-gene based transcription assays and siRNA/shRNA-based gene silencing approaches revealed that this interaction is crucial for full activation of HNF4α-mediated transcription, especially expression of target genes implicated in glucose-stimulated insulin secretion. Selected MODY mutations at the LXXLL motif binding pocket disrupt these interactions and cause impaired insulin secretion through a 'loss-of-function' mechanism.

摘要

独特的核受体肝细胞核因子 4α(HNF4α)是胰腺β细胞早期发育和正常功能所必需的转录调节因子,其突变是一种称为年轻型成年发病型糖尿病 1 型(MODY1)的显性遗传性糖尿病的单基因原因。作为一种基因特异性转录因子,HNF4α 通过各种分子相互作用发挥其功能,但它的蛋白质募集网络尚未完全表征。在这里,我们报告了 MED25 作为 HNF4α 在胰腺β细胞中的结合伴侣之一的鉴定,导致胰岛素分泌受损,而 MODY 患者的胰岛素分泌受损。MED25 是 Mediator 复合物的一个亚基,是包括核受体在内的各种转录因子诱导 RNA 聚合酶 II 转录所必需的。这种 HNF4α-MED25 相互作用最初是通过酵母双杂交方法鉴定的,通过体内和体外分析得到证实,并被证明以配体非依赖性的方式通过 MED25-LXXLL 基序介导。基于报告基因的转录分析和基于 siRNA/shRNA 的基因沉默方法表明,这种相互作用对于 HNF4α 介导的转录的完全激活至关重要,特别是对涉及葡萄糖刺激的胰岛素分泌的靶基因的表达至关重要。该结合口袋的 LXXLL 基序上的选定 MODY 突变破坏了这些相互作用,并通过“功能丧失”机制导致胰岛素分泌受损。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/c7a5d038a03e/pone.0044007.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/72c1c4ed3a61/pone.0044007.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/15a05d9c47c2/pone.0044007.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/7e61f2f16d45/pone.0044007.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/5467da2e667e/pone.0044007.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/c7a5d038a03e/pone.0044007.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/72c1c4ed3a61/pone.0044007.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/15a05d9c47c2/pone.0044007.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/7e61f2f16d45/pone.0044007.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/5467da2e667e/pone.0044007.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3cf/3431373/c7a5d038a03e/pone.0044007.g005.jpg

相似文献

1
MED25 is a mediator component of HNF4α-driven transcription leading to insulin secretion in pancreatic beta-cells.MED25 是 HNF4α 驱动的转录的中介成分,导致胰岛β细胞中的胰岛素分泌。
PLoS One. 2012;7(8):e44007. doi: 10.1371/journal.pone.0044007. Epub 2012 Aug 30.
2
ErbB3-binding protein 1 (EBP1) represses HNF4α-mediated transcription and insulin secretion in pancreatic β-cells.erbB3 结合蛋白 1(EBP1)在胰岛β细胞中抑制 HNF4α 介导的转录和胰岛素分泌。
J Biol Chem. 2019 Sep 20;294(38):13983-13994. doi: 10.1074/jbc.RA119.009558. Epub 2019 Jul 30.
3
Roles of HNF1α and HNF4α in pancreatic β-cells: lessons from a monogenic form of diabetes (MODY).肝细胞核因子1α和肝细胞核因子4α在胰腺β细胞中的作用:来自单基因糖尿病(青少年发病的成年型糖尿病)的经验教训。
Vitam Horm. 2014;95:407-23. doi: 10.1016/B978-0-12-800174-5.00016-8.
4
Dimerization defective MODY mutations of hepatocyte nuclear factor 4α.肝细胞核因子4α的二聚化缺陷型青少年发病的成年型糖尿病突变
Mutat Res. 2019 Mar;814:1-6. doi: 10.1016/j.mrfmmm.2019.01.002. Epub 2019 Jan 9.
5
Probing the effect of MODY mutations near the co-activator-binding pocket of HNF4α.探究MODY突变对肝细胞核因子4α共激活因子结合口袋附近的影响。
Biosci Rep. 2011 Oct;31(5):411-9. doi: 10.1042/BSR20110013.
6
The MODY1 gene for hepatocyte nuclear factor 4alpha and a feedback loop control COUP-TFII expression in pancreatic beta cells.肝细胞细胞核因子4α的MODY1基因及一个反馈回路控制胰腺β细胞中COUP-TFII的表达。
Mol Cell Biol. 2008 Jul;28(14):4588-97. doi: 10.1128/MCB.01191-07. Epub 2008 May 12.
7
Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta -cell genes implicated in glucose metabolism and nutrient-induced insulin secretion.肝细胞核因子4α调节参与葡萄糖代谢和营养物质诱导的胰岛素分泌的胰腺β细胞基因的表达。
J Biol Chem. 2000 Nov 17;275(46):35953-9. doi: 10.1074/jbc.M006612200.
8
Epigenetic modification of histone 3 lysine 27: mediator subunit MED25 is required for the dissociation of polycomb repressive complex 2 from the promoter of cytochrome P450 2C9.组蛋白3赖氨酸27的表观遗传修饰:中介亚基MED25是多梳抑制复合物2从细胞色素P450 2C9启动子解离所必需的。
J Biol Chem. 2015 Jan 23;290(4):2264-78. doi: 10.1074/jbc.M114.579474. Epub 2014 Nov 12.
9
Med25 is required for RNA polymerase II recruitment to specific promoters, thus regulating xenobiotic and lipid metabolism in human liver.Med25 对于 RNA 聚合酶 II 招募到特定启动子是必需的,从而调节人肝脏中的外来物质和脂质代谢。
Mol Cell Biol. 2011 Feb;31(3):466-81. doi: 10.1128/MCB.00847-10. Epub 2010 Dec 6.
10
Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells.肝细胞核因子-4α对于胰腺β细胞的葡萄糖刺激的胰岛素分泌至关重要。
J Biol Chem. 2006 Feb 24;281(8):5246-57. doi: 10.1074/jbc.M507496200. Epub 2005 Dec 23.

引用本文的文献

1
The Mediator Complex: A Regulatory Hub for Transcriptional Activity of Nuclear Receptors.中介体复合物:核受体转录活性的调控枢纽
Cells. 2025 Aug 28;14(17):1335. doi: 10.3390/cells14171335.
2
Mutational landscapes of HNF MODY gene products display a wide distribution with functional implications.肝细胞核因子(HNF)-成人发病型糖尿病(MODY)基因产物的突变图谱显示出广泛分布并具有功能意义。
Endocr Connect. 2025 Sep 2;14(9). doi: 10.1530/EC-25-0345. Print 2025 Sep 1.
3
Regulation of the RNA polymerase II pre-initiation complex by its associated coactivators.

本文引用的文献

1
Interactions between subunits of the Mediator complex with gene-specific transcription factors.中介复合物亚基与基因特异性转录因子之间的相互作用。
Semin Cell Dev Biol. 2011 Sep;22(7):759-68. doi: 10.1016/j.semcdb.2011.07.022. Epub 2011 Aug 4.
2
Discovering small-molecule estrogen receptor α/coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency.发现小分子雌激素受体 α/共激活剂结合抑制剂:高通量筛选、配体开发和增强效力的模型。
ChemMedChem. 2011 Apr 4;6(4):654-66. doi: 10.1002/cmdc.201000507. Epub 2011 Mar 1.
3
Function and regulation of the Mediator complex.
RNA聚合酶II预起始复合物受其相关共激活因子的调控。
Nat Rev Genet. 2023 Nov;24(11):767-782. doi: 10.1038/s41576-023-00630-9. Epub 2023 Aug 2.
4
High-Throughput Sequencing Data Reveal an Antiangiogenic Role of HNF4A-Mediated CACNA1A/VEGFA Axis in Proliferative Diabetic Retinopathy.高通量测序数据显示 HNF4A 介导的 CACNA1A/VEGFA 轴在增殖性糖尿病视网膜病变中的抗血管生成作用。
Invest Ophthalmol Vis Sci. 2023 Jun 1;64(7):32. doi: 10.1167/iovs.64.7.32.
5
The Contribution of Transcriptional Coregulators in the Maintenance of β-cell Function and Identity.转录共激活因子在维持β细胞功能和特性中的作用。
Endocrinology. 2021 Feb 1;162(2). doi: 10.1210/endocr/bqaa213.
6
ErbB3-binding protein 1 (EBP1) represses HNF4α-mediated transcription and insulin secretion in pancreatic β-cells.erbB3 结合蛋白 1(EBP1)在胰岛β细胞中抑制 HNF4α 介导的转录和胰岛素分泌。
J Biol Chem. 2019 Sep 20;294(38):13983-13994. doi: 10.1074/jbc.RA119.009558. Epub 2019 Jul 30.
7
Novel mechanisms of regulation of the expression and transcriptional activity of hepatocyte nuclear factor 4α.肝细胞核因子 4α 表达和转录活性调节的新机制。
J Cell Biochem. 2019 Jan;120(1):519-532. doi: 10.1002/jcb.27407. Epub 2018 Sep 7.
8
The role of prostate tumor overexpressed 1 in cancer progression.前列腺肿瘤过表达蛋白1在癌症进展中的作用。
Oncotarget. 2017 Feb 14;8(7):12451-12471. doi: 10.18632/oncotarget.14104.
9
Med25 is required for estrogen receptor alpha (ERα)-mediated regulation of human CYP2C9 expression.Med25 对于雌激素受体 α (ERα) 介导的人 CYP2C9 表达的调节是必需的。
Biochem Pharmacol. 2014 Aug 15;90(4):425-31. doi: 10.1016/j.bcp.2014.06.016. Epub 2014 Jun 21.
10
Interaction studies of the human and Arabidopsis thaliana Med25-ACID proteins with the herpes simplex virus VP16- and plant-specific Dreb2a transcription factors.人类和拟南芥Med25-ACID蛋白与单纯疱疹病毒VP16及植物特异性Dreb2a转录因子的相互作用研究。
PLoS One. 2014 May 29;9(5):e98575. doi: 10.1371/journal.pone.0098575. eCollection 2014.
中介复合物的功能和调节。
Curr Opin Genet Dev. 2011 Apr;21(2):225-30. doi: 10.1016/j.gde.2011.01.013. Epub 2011 Feb 15.
4
Probing the effect of MODY mutations near the co-activator-binding pocket of HNF4α.探究MODY突变对肝细胞核因子4α共激活因子结合口袋附近的影响。
Biosci Rep. 2011 Oct;31(5):411-9. doi: 10.1042/BSR20110013.
5
Structure-based approach for the discovery of novel selective estrogen receptor modulators.基于结构的新型选择性雌激素受体调节剂发现方法。
Curr Med Chem. 2011;18(8):1188-94. doi: 10.2174/092986711795029645.
6
Med25 is required for RNA polymerase II recruitment to specific promoters, thus regulating xenobiotic and lipid metabolism in human liver.Med25 对于 RNA 聚合酶 II 招募到特定启动子是必需的,从而调节人肝脏中的外来物质和脂质代谢。
Mol Cell Biol. 2011 Feb;31(3):466-81. doi: 10.1128/MCB.00847-10. Epub 2010 Dec 6.
7
Nuclear receptor coregulators as a new paradigm for therapeutic targeting.核受体共调节剂作为治疗靶点的新模式。
Adv Drug Deliv Rev. 2010 Oct 30;62(13):1227-37. doi: 10.1016/j.addr.2010.09.016. Epub 2010 Oct 7.
8
Selectively targeting estrogen receptors for cancer treatment.针对癌症治疗的雌激素受体选择性靶向。
Adv Drug Deliv Rev. 2010 Oct 30;62(13):1265-76. doi: 10.1016/j.addr.2010.08.001. Epub 2010 Aug 10.
9
Orphan nuclear receptors as targets for drug development.孤儿核受体作为药物开发的靶点。
Pharm Res. 2010 Aug;27(8):1439-68. doi: 10.1007/s11095-010-0117-7. Epub 2010 Apr 6.
10
LXXLL peptide mimetics as inhibitors of the interaction of vitamin D receptor with coactivators.LXXLL 肽模拟物作为维生素 D 受体与共激活因子相互作用的抑制剂。
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1712-7. doi: 10.1016/j.bmcl.2010.01.079. Epub 2010 Jan 21.